The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 02, 2016

Filed:

Sep. 11, 2012
Applicants:

Dominique Surleraux, Wauthier-Braine, BE;

Cyril B. Dousson, Canet, FR;

Gilles Gosselin, Montpellier, FR;

David Dukhan, Saint Gely du Fesc, FR;

Claire Pierra, Montarnaud, FR;

Jerome Peyronnet, Jacou, FR;

Inventors:

Dominique Surleraux, Wauthier-Braine, BE;

Cyril B. Dousson, Canet, FR;

Gilles Gosselin, Montpellier, FR;

David Dukhan, Saint Gely du Fesc, FR;

Claire Pierra, Montarnaud, FR;

Jerome Peyronnet, Jacou, FR;

Assignee:

IDENIX PHARMACEUTICALS LLC, Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/04 (2006.01); A61K 31/70 (2006.01); C07H 19/04 (2006.01); C07H 19/10 (2006.01); C07H 19/048 (2006.01); C07H 19/20 (2006.01); C07H 19/16 (2006.01); C07H 19/207 (2006.01);
U.S. Cl.
CPC ...
C07H 19/10 (2013.01); C07H 19/16 (2013.01); C07H 19/207 (2013.01);
Abstract

Provided herein are compounds, compositions and methods for the treatment of liver disorders, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, provided herein are compounds according to Formula I: or a pharmaceutically acceptable salt, solvate, tautomeric or polymorphic form thereof.


Find Patent Forward Citations

Loading…